Status:
COMPLETED
Observational Study on Metabolism and Psychopathology in Transsexual Patients
Lead Sponsor:
Max-Planck-Institute of Psychiatry
Collaborating Sponsors:
University of Erlangen-Nürnberg Medical School
Institute for Sex Research and Forensic Psychiatry, Hamburg, Germany
Conditions:
Transsexualism
Eligibility:
All Genders
18-70 years
Brief Summary
Gender identity disorders (also known as transsexualism) is defined as a condition in which a person with apparently normal somatic sexual differentiation is convinced that he or she is actually a mem...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients with the diagnosis gender identity disorder (ICD-10: F64.0), who have given written informed consent following adequate oral and written information.
- General Exclusion criteria
- Patients below the age of 18
- Legally incompetent patients
- Prior intake of cross-sex hormones
- Missing written informed consent
- Intersexuality
Exclusion
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02185274
Start Date
October 1 2013
End Date
November 30 2019
Last Update
February 25 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gynaecological department of the University hospital of Erlangen
Erlangen, Germany, 91054
2
Institute for Sex Research and Forensic Psychiatry
Hamburg, Germany, 20246
3
Hormon- und Stoffwechselzentrum München
Munich, Germany, 80333